Skip to main content

Select Drug Profiles

Lytgobi FDA Approved for Intrahepatic Cholangiocarcinoma with FGFR2 Fusion

The Role of Non-Statin Lipid-Lowering Therapy in Older Adults with ASCVD

Interview with the Innovators

A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer

Brad Bailey, Chris Cozic

Conference Highlights ASCO

Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer

Minimizing the Burden of Cardiovascular Disease: A Need for Lipid-Lowering Strategies Beyond Statins

Interview with the Innovators

Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer

Robyn Bilmes, Leslie Amendola

Convergence: Up Close and Personal

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Original Research

Real-World Treatment Patterns and Healthcare Costs Among Patients with FL with Early Treatment Failure of First-Line Chemoimmunotherapy

Lori A. Leslie, MD, Bruno Emond, MSc, Marie-Hélène Lafeuille, MA, Maude Vermette-Laforme, BSc, Patrick Lefebvre, MA, Qing Huang, PhD, MHS

Lori A. Leslie, MD; Bruno Emond, MSc; Marie-Hélène Lafeuille, MA; Maude Vermette-Laforme, BSc; Patrick Lefebvre, MA; Qing Huang, PhD, MHS

Original Research, Practice Management

Budget Impact of Intravenous Cetirizine Hydrochloride for the Treatment of Acute Urticaria in the Emergency Department Setting

Lisa M. Bloudek, PharmD, MS, LoAn K. Ho, PharmD, Neha Kapur, PharmD, Lonnie D. Brent, PharmD

Lisa M. Bloudek, PharmD, MS; LoAn K. Ho, PharmD; Neha Kapur, PharmD; Lonnie D. Brent, PharmD

Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma

Page 13 of 244
Results 121 - 130 of 2434